SCHEMBL10367496

SCHEMBL10367496

Oc1cccc(CN2CCCCCCC2)c1

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
TDP1 Q9NUW8 1/20 0.64
CYP2D6 P10635 2/20 0.61
CYP2C9 P11712 1/20 0.61
HIF1A Q16665 1/20 0.61
PRMT6 Q96LA8 1/20 0.61
KDM4E B2RXH2 1/20 0.58
GAA P10253 1/20 0.58
DRD2 P14416 2/20 0.55
DRD3 P35462 1/20 0.55
HRH3 Q9Y5N1 1/20 0.55
CYP2C19 P33261 1/20 0.55
BCL2L1 Q07817 1/20 0.52
POLB P06746 1/20 0.51
HTT P42858 1/20 0.51
HPGD P15428 1/20 0.51
ALOX15 P16050 1/20 0.51
HBB P68871 1/20 0.51
HSD17B10 Q99714 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3154468 1.00 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2TDP1CYP2D6CYP2C9
SCHEMBL10370403 1.00 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2TDP1CYP2D6CYP2C9
SCHEMBL29966226 1.00 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2TDP1CYP2D6CYP2C9
SCHEMBL6310987 0.98 PRMT6 (0.62) ALDH1A1SMN1; SMN2TDP1CYP2D6CYP2C9
SCHEMBL27650580 0.94 PRMT6 (0.58) ALDH1A1SMN1; SMN2TDP1CYP2D6CYP2C9
SCHEMBL11339852 0.86 PRMT6 (0.78) ALDH1A1SMN1; SMN2TDP1CYP2D6CYP2C9
SCHEMBL11192726 0.86 PRMT6 (0.78) ALDH1A1SMN1; SMN2TDP1CYP2D6CYP2C9
SCHEMBL7955357 0.82 HRH3 (0.63) DRD2HRH3
SCHEMBL24556358 0.82 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2TDP1KDM4EDRD2
SCHEMBL10370696 0.82 MC4R (0.62) ALDH1A1PRMT6KDM4EDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0150073-B1 3,4-DISUBSTITUTED-1,2,5-OXADIAZOLES HAVING HISTAMINE H2-RECEPTOR ANTAGONIST ACTIVITY Bristol-Myers Squibb Company (US) 1990-09-26 EP disclosed
EP-0150073-A1 3,4-Disubstituted-1,2,5-oxadiazoles having histamine H2-receptor antagonist activity Bristol-Myers Squibb Company (US) 1985-07-31 EP disclosed
US-4507485-A 3,4-Disubstituted-1,2,5-oxadiazoles having histamine H2 -receptor antagonist activity BRISTOL-MYERS COMPANY (US) 1985-03-26 US disclosed